Asthma therapy: Does your patient need inhaled steroids?

Consultant

Volumn 43, Issue 9, 2003, Pages 1073-1077

  Yawn, Barbara P ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b OLMSTED MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; HISTAMINE;

ARTICLE; ASTHMA; CATARACT; CLINICAL FEATURE; CORTICOSTEROID INDUCED OSTEOPOROSIS; COUGHING; DISEASE SEVERITY; DRUG INDICATION; DYSPNEA; FORCED EXPIRATORY VOLUME; GLAUCOMA; HUMAN; LONG TERM CARE; NIGHTMARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEASONAL VARIATION; SMOKING HABIT; TREATMENT PLANNING; WHEEZING;

EID: 0041322684     PISSN: 00107069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med. 2000;343:1064-1069.
2. Van Bever HP, Desager KN, Lijssens N, et al. Does treatment of asthmatic children with inhaled corticosteroids affect their adult height? Pediatr Pulmonol. 1999;27:369-375.
3. Silverstein MD, Yunginger JW, Reed CE, et al. Attained adult height after childhood asthma: effect of glucocorticoid therapy. J Allergy Clin Immunol. 1997;99:466-474.
4. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. Update on Selected Topics-2002. J Allergy Clin Immunol. 2002;110 (suppl):S141-S219. Also available at: http://www. nhlbi.nih.gov/guidelines/asthma. Accessed May 15, 2003.
5. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med. 1995;332:868-875.
6. Management of Chronic Asthma. Summary, Evidence Report/Technology Assessment: Number 44. Rockville, Md: Agency for Healthcare Research and Quality; 2001. AHRQ publication 01-EO43. Also available at: http://www.ahrq.gov/clinic/epcsums/ asthmasum.htm. Accessed June 4, 2003.
7. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med. 2001;344:350-362.
8. National Asthma Education and Prevention Program. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md: National Institutes of Health; 1997.
9. Mannino DM, Homa DM, Akinbami LJ, et al. Surveillance for asthma-United States, 1980-1999. MMWR. 2002;51:1-13.
10. Lara M, Nicholas W, Morton S, et al, eds. Improving Childhood Asthma Outcomes in the United States. A Blueprint for Policy Action. Santa Monica, Calif: Rand Corporation; 2001.
11. The American Academy of Allergy, Asthma & Immunology, Inc. The Allergy Report Milwaukee: AAAAI; 2000.
12. Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. N Engl J Med. 1995;332:133-138.
13. Mannino DM, Homa DM, Pertowski CA, et al. Surveillance for asthma-United States, 1960-1995. MMWR. 1998;47:1-27.
14. Drazen JM, Israel E, Boushey HA, et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med. 1996;335:841-847.
15. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000;343:1054-1063.
16. Yawn BP, Wollan PC, Kurland M, et al. A longitudinal study of the prevalence of asthma in a community population of school-age children. J Pediatr. 2002;140:576-581.
17. Silver EJ, Crain EF, Weiss KB. Burden of wheezing illness among US children reported by parents not to have asthma. J Asthma. 1998;35:437-443.
18. Kemp JP, Kemp JA. Management of asthma in children. Am Fam Physician. 2001;63:1341-1348.